Slide of the Month
Common practices in 33 facilitated regulatory pathways used by 29 emerging national regulatory authorities.
CONTACT US
MEMBER LOGIN
WHERE TO MEET US
Attendance at upcoming meetings and conferences
READ
Our most recent publications
R&D Briefing 59: The impact of the evolving regulatory environment on the approval of new medicines across six major authorities 2006-2015
R&D Briefing 58: The changing regulatory environment in Latin America. Focus on good review practices
Abstract: Liberti L, Breckenridge A, Hoekman J, Leufkens H, Lumpkin M, McAuslane N, Stolk P, Zhi K, Rägo L. Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authorities. J Public Health Policy. 2016 Mar 10. doi: 10.1057/jphp.2016.8. [Epub ahead of print]
View more